Phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles

Phthalocyanine-based nanoparticles were prepared by solvothermal method, which solved the solubility of tetracarboxyphthalocyanine zinc in neutral aqueous solution and the toxicity of polyethyleneimine, and achieved efficient bactericidal and biocompatibility of Gram-positive bacteria. Sex enhancement promotes wound healing in mice.

CN118903448AInactive Publication Date: 2024-11-08FUZHOU UNIV
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410927382.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-11
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The poor solubility of tetracarboxyphthalocyanine zinc in neutral aqueous solutions and the severe hemolytic and cytotoxicity of polyethyleneimine limit its application in photodynamic antibacterial therapy.

Method used

Phthalocyanine-based nanoparticles (PEI-NPs) were prepared by solvothermal method by reacting tetracarboxylic phthalocyanine with polyethyleneimine to improve the water solubility of phthalocyanine zinc, and dark green oil droplets were generated by ultrasonic and hydrothermal reaction. phthalocyanine-based nanoparticles are reduced in vivo toxicity.

Benefits of technology

PEI-NPs significantly improve the antibacterial activity of tetracarboxyphthalocyanine zinc, have efficient bactericidal ability on Gram-positive strains, reduce hemolyticity and cytotoxicity, and improve biocompatibility. It is significantly in the mouse local wound infection model. Reduce bacterial count and promote wound healing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention discloses phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles as well as a preparation method and application thereof, and belongs to the technical field of nano material preparation. The phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles (PEI-NPs) are prepared by adopting a solvothermal method, taking zinc tetracarboxyl phthalocyanine as a skeleton and utilizing low-molecular-weight polyethyleneimine (PEI) as a bridging group, so that the antibacterial property of the zinc tetracarboxyl phthalocyanine and the biocompatibility of the PEI are effectively improved, and an antibacterial material is provided for the fields of wound bacterial infection treatment and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of nano material preparation, and specifically relates to phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles and a preparation method and application thereof. Background Art

[0002] Bacterial infections are a serious threat to human life and health. More importantly, as more and more bacteria have become resistant to antibiotics, the treatment of bacterial infections has become increasingly difficult. Therefore, researchers are actively looking for new treatment strategies to address this problem.

[0003] Photodynamic therapy (PDT) is an emerging antibacterial treatment method. Its advantage lies in its non-specific bactericidal mechanism, which makes it impossible for pathogens to develop resistance to it. Therefore, it is regarded as a new strategy for the treatment of drug-resistant bacteria. Compared with traditional photosensitizers such as porphyrins and methylene blue, phthalocyanine photosensitizers have the advantages of deep treatment depth, high ROS production rate and low skin phototoxicity. However, the poor solubility of phthalocyanine photosensitizers in neutral aqueous solutions limits their wide application in PDT. PEI, as a water-soluble polymer with cationic properties, has become an effective means to improve the water solubility of photosensitizers. In addition, PEI is also an antibacterial agent. However, the biocompatibility issues caused by the severe hemolysis and cytotoxicity of PEI make it impossible to use it for in vivo antibacterial treatment. Summary of the invention

[0004] The purpose of the present invention is to provide a phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticle and a preparation method and application thereof, which can effectively improve the solubility of tetracarboxyl phthalocyanine zinc in a neutral aqueous solution and enhance its antibacterial photodynamic therapy (aPDT) effect.

[0005] To achieve the above object, the present invention adopts the following technical solution:

[0006] Weigh tetracarboxyl phthalocyanine zinc (0.25 g, 0.33 mmol) and place it in a 50 mL centrifuge tube, add N, N-dimethylformamide (DMF, 10 mL) and mix thoroughly, ultrasonicate for 10 min until completely dissolved; weigh linear polyethyleneimine (PEI, 2.10 g) with a molecular weight of 600 and place it in another 50 mL centrifuge tube, add DMF (5 mL) and place it in an ultrasonic cleaner for ultrasonication for 10 min until completely dissolved. Mix the liquids in the above two centrifuge tubes evenly and continue ultrasonication for 1 h, transfer the mixed liquid to a 50 mL hydrothermal reactor, and place it at 180 ° C for 16 h. After the reaction is completed, the reaction liquid is cooled to room temperature to obtain a dark green liquid. The dark green liquid is centrifuged at 8000 r / min for 10 min to discard the large particle precipitate, filter the supernatant with a 0.22 μm filter membrane and seal the liquid in a dialysis bag with a molecular weight of 3.5 kDa, intrude 1 L of pure water for 24 h, and replace the dialysate every 4 h. The sample was collected and filtered again with a 0.22 μm filter membrane, and finally the sample was freeze-dried to obtain dark green oil droplet-like phthalocyanine-based nanoparticles (PEI-NPs).

[0007] The structural formula of tetracarboxyl phthalocyanine zinc is:

[0008]

[0009] The structural formula of polyethyleneimine is:

[0010]

[0011] The beneficial effects of the present invention are:

[0012] (1) The present invention adopts a solvothermal method, with tetracarboxylic phthalocyanine zinc as the skeleton and PEI as the bridging group, to successfully prepare phthalocyanine-based nanoparticles (PEI-NPs). This method effectively improves the solubility of tetracarboxylic phthalocyanine zinc in neutral aqueous solution. The surface of PEI-NPs carries a positive charge, which helps to enhance the bacterial uptake of tetracarboxylic phthalocyanine zinc, thereby enhancing the aPDT effect. It has the advantages of simple operation and high antibacterial activity of the product. The PEI-NPs have high antibacterial activity against Gram-positive strains such as Staphylococcus aureus and MRSA. PEI-NPs kill bacteria through multiple mechanisms such as producing a large amount of ROS, enhancing bacterial uptake of it, and destroying bacterial cell membranes. More importantly, PEI-NPs effectively reduce the hemolysis and cytotoxicity of free PEI and improve biocompatibility. In a mouse local wound infection model, the wound healing rate after PEI-NPs synergistic red light treatment was 84%, and the number of wound colonies was reduced from 2.27×10 6 CFU / mL decreased to 8.03×10 4CFU / mL, the number of wound colonies was reduced by 97%. In addition, PEI-NPs synergistically with red light treatment did not affect the weight gain of mice.

[0013] (2) The present invention prepares PEI-NPs by reacting PEI with tetracarboxylic phthalocyanine zinc, which effectively reduces the hemolytic and cytotoxic properties of free PEI, improves the biocompatibility of PEI, and provides a new idea for the clinical application of PEI.

[0014] (3) The present invention applied PEI-NPs to a mouse local wound infection model and preliminarily demonstrated its antibacterial activity in vivo, providing reference value for subsequent inventions. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 This is the antibacterial effect of PEI-NPs on bioluminescent Escherichia coli.

[0016] Figure 2 This is the antibacterial effect diagram of PEI-NPs against Escherichia coli, Staphylococcus aureus and MRSA under the assistance of 680nm light.

[0017] Figure 3 The cytotoxicity of PEI-NPs to EA·hy 926 cells.

[0018] Figure 4 The hemolytic property of PEI-NPs.

[0019] Figure 5 Schematic diagram of the mouse wound healing experiment using PEI-NPs and its effect in promoting wound healing. DETAILED DESCRIPTION

[0020] In order to make the contents of the present invention easier to understand, the technical solution of the present invention is further described below in conjunction with specific implementation methods, but the present invention is not limited thereto.

[0021] The specific steps of a method for preparing phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles are as follows:

[0022] Weigh tetracarboxyl phthalocyanine zinc (0.25 g, 0.33 mmol) and place it in a 50 mL centrifuge tube, add N, N-dimethylformamide (DMF, 10 mL) and mix thoroughly, ultrasonicate for 10 min until completely dissolved; weigh linear polyethyleneimine (PEI, 2.10 g) with a molecular weight of 600 and place it in another 50 mL centrifuge tube, add DMF (5 mL) and place it in an ultrasonic cleaner for ultrasonication for 10 min until completely dissolved. Mix the liquids in the above two centrifuge tubes evenly and continue ultrasonication for 1 h, transfer the mixed liquid to a 50 mL hydrothermal reactor, and place it at 180 ° C for 16 h. After the reaction is completed, the reaction liquid is cooled to room temperature to obtain a dark green liquid. The dark green liquid is centrifuged at 8000 r / min for 10 min to discard the large particle precipitate, filter the supernatant with a 0.22 μm filter membrane and seal the liquid in a dialysis bag with a molecular weight of 3.5 kDa, intrude 1 L of pure water for 24 h, and replace the dialysate every 4 h. The sample was collected and filtered again with a 0.22 μm filter membrane, and finally the sample was freeze-dried to obtain dark green oil droplet-like phthalocyanine-based nanoparticles (PEI-NPs).

[0023] The structural formula of tetracarboxyl phthalocyanine zinc is:

[0024]

[0025] The structural formula of polyethyleneimine is:

[0026]

[0027] Example 1: Antibacterial properties of PEI-NPs

[0028] The experimental strain is bioluminescent Escherichia coli, and the specific steps are as follows:

[0029] The drug was diluted three times with PBS in a black 96-well plate, and the diluted bacterial solution (concentration of about 10 6 CFU / mL) 100μL, the total volume of each well is 200μL. At the same time, prepare the corresponding light-proof group on another black 96-well plate. Incubate for 10 minutes in the dark, and then illuminate the light group (12 minutes, 16.6mW / cm 2 , voltage 22V, light dose 12J / cm 2 ), and then incubate for 10 min. The luminescence value of each group was measured using an ELISA instrument to calculate the antibacterial rate.

[0030] The antibacterial rate (I) is calculated according to the following formula: I (%) = (L 1 -L 2 ) / L 1 ×100%; where L 1 Represents the luminescence intensity of the control group, L2 Represents the luminescence intensity of the experimental group.

[0031] Results Figure 1 , at 12J / cm 2 Later, the IC values ​​of PEI-NPs and Pc-NPs on bioluminescent Escherichia coli were 50 They are 7.21×10 -4 g / L and 0.40g / L. In the dark treatment group, the IC values ​​of PEI-NPs and Pc-NPs on bioluminescent Escherichia coli were 50 0.16g / L and 0.42g / L respectively; PEI and ZnPc(COONa) alone 4 The IC50 of the mixture of PEI and ZnPc against bioluminescent Escherichia coli was 0.27 g / L and 0.12 g / L, respectively. The results showed that the antibacterial activity of PEI-NPs was superior to that of Pc-NPs, PEI alone, and ZnPc(COONa) 4 + PEI mixture. In fact, with Pc-NPs, PEI alone and ZnPc(COONa) 4 Compared with the + PEI mixture group, the aPDT effect of PEI-NPs on bioluminescent Escherichia coli was increased by 554, 373, and 165 times, respectively, indicating that PEI-NPs have efficient antibacterial activity against bioluminescent Escherichia coli.

[0032] Example 2: Antibacterial properties of PEI-NPs

[0033] The experimental strains were Gram-positive Staphylococcus aureus (S. aurues, ATCC 6358), Gram-negative Escherichia coli (E. coli, ATCC 8739) and methicillin-resistant Staphylococcus aureus (MRSA, ATCC 33591). The specific steps are as follows:

[0034] A 5 g / L PEI-NPs solution was added to a transparent 96-well plate, and then a concentration of about 10 6 CFU / mL of bacterial solution, three parallel groups. In addition, a negative control (only blank culture medium without bacterial solution) and a positive control (bacterial broth without culture medium) were made on the same plate. At the same time, a corresponding light-proof group was prepared on another transparent 96-well plate. Incubate in the dark for 10 minutes, and then illuminate the light group for 12 minutes (16.6mW / cm 2 , voltage 22V, light dose 12J / cm 2) and then use sterile PBS to dilute each group into different concentration gradients, take 100 μL and smear it on the pre-configured bacterial culture plate, and count the number of colonies after culturing for 20 hours. The antibacterial rate is calculated according to the following formula: R (%) = (BA) / B × 100%; where: R—antibacterial rate (%); A—average colony count of the test sample; B—average colony count of the control sample.

[0035] Results Figure 2 , at 12J / cm 2 After that, the effect of PEI-NPs on the growth and proliferation of E. coli was relatively weak. In the absence of light, the antibacterial rate of PEI-NPs against E. coli was 46% at a concentration of 2.50g / L. After light exposure, the antibacterial rate increased to 56%, and did not show a significant killing effect. After PEI-NPs were irradiated with red light at a concentration of 1.25g / L, the growth of S. aureus and MRSA was effectively inhibited, with the antibacterial rates of S. aureus and MRSA reaching 99.99% and 96%, respectively. There was almost no colony formation on the S. aureus agar plate, and a small amount of colony formation on the MRSA agar plate. On the contrary, at the same concentration, when PEI-NPs did not cooperate with the effect of red light, it did not lead to a significant decrease in the activity of MRSA bacteria (the antibacterial rate was 31%). This shows that PEI-NPs can efficiently kill MRSA in cooperation with photodynamics.

[0036] Example 3: Cytotoxicity of PEI-NPs to EA·hy 926 cells

[0037] (1) Cell preparation: Human umbilical vein cell fusion cells (EA·hy 926 cells) were cultured to the seventh generation using DMEM medium containing 10% fetal bovine serum (FBS) and 1% (containing a mixture of penicillin and streptomycin). Cell experiments can be performed when the cells are in the logarithmic growth phase. The cell counting reagent CCK-8 reagent was used to evaluate the potential toxicity of PEI-NPs to EA·hy 926 cells.

[0038] (2) Adjust the cell suspension to contain 10,000 cells per 100 μL, and add the cell suspension (100 μL) to each well of the 96-well plate except for the reserved 6 blank control wells. Add only DMEM medium (100 μL) to the blank control wells without adding cells. Then, place the 96-well plate in a 37°C incubator (containing 5% CO 2 The cells were cultured for 24 h until they were completely attached to the wall.

[0039] (3) Remove the DMEM medium, resuspend with PBS, wash twice, add 100 μL of drugs of different concentrations (1.25, 0.63, 0.31 and 0.16 g / L), and add DMEM medium (100 μL) to the blank group. Place the 96-well plate at 37°C, CO 2 Incubate the cells in a cell culture incubator at a CO concentration of 5% and a humidity of 100% for 24 h.

[0040] (4) After the drug and cells are fully in contact, the drug is removed and the cells are washed three times with PBS. Then, DMEM medium (100 μL) containing 10% CCK-8 is added to the sample and placed in an incubator at 37°C (containing 5% CO). 2 ) were incubated for 75 min, and the absorbance (A450) of each group at 450 nm was measured by an ELISA reader. Four parallel experiments were set up.

[0041] (5) Cell viability (V) was calculated according to the following formula: V (%) = (As-Ab) / (Ac-Ab) × 100%; wherein As represents the absorbance of the wells containing cells, CCK-8 and drugs at 450 nm, Ac represents the absorbance of the wells containing cells and CCK-8 at 450 nm, and Ab represents the absorbance of the wells containing only CCK-8 at 450 nm.

[0042] Results Figure 3 , when the concentration of PEI-NPs was in the range of 0.16 to 0.31 g / L, the cell viability was 96%, indicating that PEI-NPs had little effect on cell viability in this concentration range. However, when the concentration of PEI-NPs was increased to 1.25 g / L, although the cell viability decreased, the relative cell viability remained above 73%. There was a negative correlation between the concentration of Pc-NPs and the viability of EA·hy 926 cells. As the concentration of Pc-NPs increased from 0.16 g / L to 1.25 g / L, the cell viability decreased from 89% to 6%. In addition, the original PEI caused the cell viability to drop sharply to 17% at a concentration of 0.16 g / L, showing strong cytotoxicity. This shows that the solvothermal reaction of PEI with ZnPc(COOH) 4 The cytotoxicity of PEI can be effectively improved by preparing it in the form of nanoparticles.

[0043] Example 4: Hemolytic activity of PEI-NPs

[0044] Healthy volunteer red blood cells (RBC) were used to evaluate the blood compatibility of PEI-NPs and Pc-NPs. Whole blood was collected from volunteers and centrifuged at 2500r / min for 10 minutes. RBCs were separated from the whole blood and washed repeatedly with PBS solution for 4 times until the supernatant had no obvious red color. Subsequently, the obtained RBCs were resuspended in PBS solution to prepare a 10% RBC dispersion.

[0045] 200 μL of RBC dispersion was added to 800 μL of PEI-NPs suspensions of different concentrations, Pc-NPs suspensions of different concentrations, PBS solution (negative control) or pure water (positive control), and the volume fraction of RBC dispersion was 2%. Subsequently, all samples were placed in a 37°C constant temperature incubator for 0.5 h. After the incubation, centrifuge at 2500 r / min for 5 min to separate the precipitated RBCs, and the supernatant was collected for later use. Finally, 200 μL of supernatant was added to a transparent 96-well plate, and its absorbance at 545 nm (A 545 ) The hemolysis rate (H) was calculated according to the following formula: H (%) = (A x -A 0 ) / (A x -A 1 )×100%; where A x A represents the absorbance of the experimental group samples at 545 nm; 0 represents the absorbance of the negative control group at 545 nm and A 1 It represents the absorbance of the positive control group at 545 nm.

[0046] Results Figure 4 ,When the maximum concentration of PEI-NPs was 2.00 g / L, the hemolysis rate was 4.73%, indicating that the PEI-NPs suspension with a concentration of less than 2.00 g / L had almost no hemolysis after incubation with red blood cells, indicating that PEI-NPs had good biocompatibility at this concentration.

[0047] Example 5: Schematic diagram of PEI-NPs wound healing experiment in mice and its effect on promoting wound healing

[0048] Preparation before the experiment: ICR male mice were raised to an average weight of 25±2g. Two days before the experiment, each mouse was injected with 60mg / (kg.d) of cyclophosphamide (CTX) aqueous solution to temporarily reduce the neutrophils of the mice and establish a cyclophosphamide immunodeficiency model to ensure the smooth progress of the experiment. The surgical forceps, scalpels and other experimental supplies required for the experiment were sterilized at high temperature. S. aureus was cultured to OD600 between 0.6 and 0.8, and the concentration of the bacterial suspension was adjusted to 108CFU / mL.

[0049] Under isoflurane anesthesia, the back skin of the mice was depilated with depilatory cream and disinfected with alcohol, and then a square full-thickness wound with a side length of 10 mm was cut on the back of each mouse with surgical scissors. Subsequently, 50 μL of pre-cultured S. aureus bacterial suspension (108 CFU / mL) was evenly applied to the wound surface of the mouse and infected for 1 hour (defined as day 0). An animal model of wound skin infection was established.

[0050] Fifteen mice were randomly divided into three groups: (1) control group (PBS), (2) PEI-NPs (1.250 g / L, 100 μL), and (3) PEI-NPs (1.250 g / L, 100 μL) + laser (680 nm, 45 W / cm 2 , 10min). After infection, mice in group (3) were irradiated with PEI-NPs and laser. Before and after irradiation, wound secretions were collected with a medical sterile cotton swab soaked in saline, and then further soaked in 1000μL of PBS solution (the bacterial suspension was diluted 1000 times at this time). The plate counting method was used to observe the number of S. aureus. During the treatment, the wounds of each group were photographed and monitored, and the wound sizes were recorded on days 0, 2, 4, 6, 8, and 10. After the treatment, the mice were killed. The wound healing rate (W) was calculated according to the following formula: W (%) = (A 0 -A) / A 0 ×100%; where A and A0 are the wound area on the specified date and the initial wound area on day 0, respectively.

[0051] Figure 5 The results showed that on the 10th day, the wounds of mice in the PEI-NPs+Light treatment group still had small scabs, and the wound healing rate was 84%. The wounds of the PEI-NPs treatment group and the PBS treatment group still had a large area of ​​unhealed wounds, with healing rates of 73% and 43%, respectively.

[0052] After infection, the number of S. aureus colonies in the wounds of mice in each group was 2.27×10 6CFU / mL. A large number of S. aureus colonies (8.33×10 5 CFU / mL), the number of colonies was only reduced by 67%; after 10 min of PEI-NPs-assisted red light irradiation, the number of colonies in the wound tissue of the PEI-NPs+Light treatment group was significantly reduced to only 8.03×10 4 CFU / mL, and the number of colonies decreased by 97%, indicating that PEI-NPs can effectively inhibit wound infection under photodynamic therapy. However, a large number of S. aureus colonies can still be observed in the wounds of the PBS treatment group, with a colony count of 2.53×10 6 CFU / mL. The results showed that when PEI-NPs and red light acted synergistically, the wound healing speed of mice was accelerated and the number of bacterial colonies in the wound was effectively reduced, thus demonstrating its efficient antibacterial ability. In addition, PEI-NPs synergistic red light treatment did not affect the weight gain of mice.

[0053] The above description is only a preferred embodiment of the present invention. All equivalent changes and modifications made according to the scope of the patent application of the present invention should fall within the scope of the present invention.

Claims

1. A method for preparing phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles, Features: The phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles are prepared by a solvent thermal method using low molecular weight polyethyleneimine and tetracarboxyl phthalocyanine zinc as raw materials.

2. The method according to claim 1, Features: The following steps are involved: (1) Mix tetracarboxyphthalocyanine zinc and N,N-dimethylformamide and sonicate until completely dissolved; (2) Mix linear polyethyleneimine with a molecular weight of 600 and N,N-dimethylformamide and sonicate until completely dissolved; (3) The solutions obtained in steps (1) and (2) are mixed, ultrasonication is continued for 1 h, solvent thermal reaction is carried out at 180 °C for 16 h, and the mixture is cooled to room temperature. The phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles are obtained by centrifugation, filtration, dialysis, and freeze drying.

3. Phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles prepared by the method according to any one of claims 1 to 2.

4. Use of phthalocyanine-polyethyleneimine photodynamic antibacterial nanoparticles prepared by the method according to any one of claims 1 to 2 in the preparation of photodynamic antibacterial materials.

Citation Information

Patent Citations

  • Protoporphyrin fluorescent carbon dot, and preparation method and application thereof

    CN107011511A

  • Photodynamic antibacterial fiber for air purification and preparation method and application thereof

    CN114855452A

  • Method for improving in-vivo antithrombotic action time and safety of cationic polyphosphate inhibitor

    CN117982671A

  • Photodynamic inactivation of viruses in blood cell-containing compositions

    US5120649A